Results 1 - 10 of 310
[PROJECT] MOPACT - MOBILISING THE POTENTIAL OF ACTIVE AGEING IN EUROPE
ID: 320333
Start date: 2013-03-01, End date: 2017-02-28
The starting point for MOPACT is the ambitious goals set by Horizon 2020 and the European Innovation Partnership Pilot Project on Active and Healthy Ageing (EIPAHA). Our response is ambitious too: we aim to provide the research and practical evidence upon which Europe can mak...
Programme: FP7-SSH
Record Number: 107822
Last updated on: 2017-07-02
[PROJECT] CRYOPRESERVATION - Improved Cryopreservation using Ice Binding Proteins
ID: 281595
Start date: 2011-11-01, End date: 2016-10-31
Several organisms have evolved specialized ice binding proteins (IBPs) that prevent their body fluids from freezing (antifreeze proteins, AFPs), inhibit recrystallization of ice in frozen tissues, or initiate freezing at moderate supercooling temperatures (ice nucleating prot...
Programme: FP7-IDEAS-ERC
Record Number: 101006
Last updated on: 2017-07-02
[PROJECT] AMPHORA - Alcohol Measures for Public Health Research Alliance (AMPHORA)
ID: 223059
Start date: 2009-01-01, End date: 2012-12-31
AMPHORA is a Europe wide project involving researches and research institutions from 14 European countries, and counterparts and organizations from all 27 Member States, that will provide new scientific evidence for the best public health measures to reduce the harm done by a...
Programme: FP7-HEALTH
Record Number: 92876
Last updated on: 2017-06-28
[PROJECT] CE-MICROARRAY - Cavity Enhanced Microarray as an Ultra-sensitive Tool to aid Sepsis Diagnosis
ID: 606618
Start date: 2014-02-01, End date: 2016-09-30
Sepsis is a life-threatening illness caused by the body’s overreaction to an infection and can be triggered either directly by infection or may occur after medical treatment or surgery.The mortality rate in patients admitted to hospital with severe sepsis is 28-50% and it rem...
Programme: FP7-SME
Record Number: 111605
Last updated on: 2017-06-26
[PROJECT] TX-FACTORS - NEW BIOLOGICAL FUNCTIONS AND THERAPEUTIC POTENTIAL OF
VASCULAR ENDOTHELIAL GROWTH FACTORS
ID: 268804
Start date: 2011-06-01, End date: 2016-05-31
This application promises to provide new treatment options for cancer and cardiovascular diseases that are the leading causes of morbidity and mortality in the western world. Current cardiovascular and cancer therapies are often insufficient, unsuccessful or not suitable for ...
Programme: FP7-IDEAS-ERC
Record Number: 99210
Last updated on: 2017-06-26
[PROJECT] UROSENSE - Biomarker Applications for Nanotechnology and Imaging in Diabetes
ID: 286386
Start date: 2012-01-01, End date: 2015-12-31
UroSense is a focussed research programme to generate new concepts from knowledge creation to knowledge transfer between innovative academic and dedicated industry partners utilising a systematic intersectoral secondment programme. The programme brings leading edge academic E...
Programme: FP7-PEOPLE
Record Number: 101741
Last updated on: 2017-06-12
[PROJECT] PNEUMONP - Nanotherapeutics to Treat Antibiotic Resistant Gram-Negative Pneumonia Infections
ID: 604434
Start date: 2014-01-01, End date: 2017-12-31
The main objective of PneumoNP is the development of a theragnostic system for the treatment of lung Gram-negative bacterial infections. As a proof of concept PneumoNP will focus the attention on Klebsiella pneumoniae caused infections. A diagnostic kit will be developed to e...
Programme: FP7-NMP
Record Number: 110689
Last updated on: 2017-06-05
[PROJECT] RADIANT - Rapid development and distribution of statistical tools for high-throughput sequencing data
ID: 305626
Start date: 2012-12-01, End date: 2015-11-30
High-throughput sequencing (HTS) is a powerful and rapidly evolving family of technologies with a multitude of applications. They include genetics of rare and common diseases, understanding of disease mechanism and progression through transcriptome and epigenome profiling, ca...
Programme: FP7-HEALTH
Record Number: 105701
Last updated on: 2017-06-05
[PROJECT] EPAD - European Prevention of Alzheimer’s Dementia Consortium
ID: 115736
Start date: 2015-01-01, End date: 2019-12-31
Background: The secondary prevention of Alzheimer’s dementia (AD) is achievable if we can identify individuals at risk of disease progression defined by biomarker evidence of AD pathology and no or only minimal clinical symptoms and engage them in a standing adaptive clinical...
Programme: FP7-JTI
Record Number: 203723
Last updated on: 2017-06-05
[PROJECT] PREDICT-IV - Profiling the toxicity of new drugs: a non animal-based approach integrating toxicodynamics and biokinetics
ID: 202222
Start date: 2008-05-01, End date: 2013-10-31
The overall aim of Predict-IV is to develop strategies to improve the assessment of drug safety in the early stage of development and late discovery phase, by an intelligent combination of non animal-based test systems, cell biology, mechanistic toxicology and in-silico model...
Programme: FP7-HEALTH
Record Number: 86700
Last updated on: 2017-05-30
List retrieved on: 2017-07-09
